VRTX Form 144: 40,000 Common Shares Filed

VRTX submitted a Form 144 notice reporting the proposed sale of 40,000 common shares.

Rhea-AI Filing Summary

VRTX submitted a Form 144 notice reporting the proposed sale of 40,000 common shares. The filing lists an aggregate dollar amount of $19,738,905.28 and shows 254,034,190 shares on the line that includes 02/27/2026.

The entries list multiple restricted stock vesting dates (02/10/2025, 02/17/2025, 02/24/2025, 02/26/2025) with vesting quantities of 9,681, 6,998, 8,282, and 15,039 shares respectively. The form identifies Fidelity Brokerage Services LLC as the broker on a NASDAQ-listed common security.

Insights

Securities Attorney

Rule 144 resale notice filed for 40,000 common shares with broker identified.

The filing line lists 40,000 common shares and an aggregate amount of $19,738,905.28, with 254,034,190 appearing on the same row alongside 02/27/2026. The broker is listed as Fidelity Brokerage Services LLC.

Several restricted stock vesting events are shown on 02/10/2025, 02/17/2025, 02/24/2025, and 02/26/2025 with specific vesting share counts in the excerpt. Timing and proceeds treatment beyond these lines are not detailed in the provided excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does VRTX's Form 144 report?

The Form 144 reports a proposed resale of 40,000 common shares with an aggregate amount of $19,738,905.28. It also lists 254,034,190 on the same data row dated 02/27/2026, and names Fidelity Brokerage Services LLC as broker.

Who is the broker listed on the VRTX filing?

The filing shows Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield RI 02917 as the broker for the common shares. The excerpt ties this broker line to the row that includes 40,000 and the aggregate dollar figure.

Does the excerpt show recent vesting activity for VRTX?

Yes, the excerpt lists restricted stock vesting events on 02/10/2025 (9,681), 02/17/2025 (6,998), 02/24/2025 (8,282), and 02/26/2025 (15,039). These appear under 'Securities To Be Sold.'

Are proceeds recipient details shown in the VRTX excerpt?

The provided lines show an aggregate dollar amount of $19,738,905.28 but do not state who will receive proceeds. The excerpt names the broker and lists share counts and dates; allocation of proceeds is not specified in the visible text.

Does the filing indicate the exchange where VRTX trades?

Yes, the data row includes NASDAQ as the market for the common security. That exchange label appears on the same line as the broker, share count, aggregate dollar amount, and the date 02/27/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 04:41 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001735944
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERTEX PHARMACEUTICALS INC / MA
SEC File Number	000-19319
Address of Issuer	50 NORTHERN AVENUE BOSTON MASSACHUSETTS 02210
Phone	6173416393
Name of Person for Whose Account the Securities are To Be Sold	Kewalramani Reshma
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	40000	19738905.28	254034190	02/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2025	Restricted Stock Vesting	Issuer			9681	02/10/2025	Compensation
Common	02/17/2025	Restricted Stock Vesting	Issuer			6998	02/17/2025	Compensation
Common	02/24/2025	Restricted Stock Vesting	Issuer			8282	02/24/2025	Compensation
Common	02/26/2025	Restricted Stock Vesting	Issuer			15039	02/26/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/27/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Reshma Kewalramani
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)